Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Perrig, M.
Right arrow Articles by Cottagnoud, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perrig, M.
Right arrow Articles by Cottagnoud, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2001) 47, 701-704
© 2001 The British Society for Antimicrobial Chemotherapy


Brief report

Efficacy of gatifloxacin alone and in combination with cefepime against penicillin-resistant Streptococcus pneumoniae in a rabbit meningitis model and in vitro

Martin Perriga, Fernando Acostaa, Marianne Cottagnouda, Cynthia M. Gerbera, Martin G. Täuberb and Philippe Cottagnoudc,*

a Department of Internal Medicine, Zieglerspital, 3007 Berne; b Institute of Medical Microbiology, University of Berne; c Department of Internal Medicine, Inselspital, 3010 Berne, Switzerland

Gatifloxacin penetrated well into cerebrospinal fluid (CSF) (49 ± 11%), measured by comparison of AUCCSF/AUCserum, and showed good bactericidal activity (leading to a decrease of 0.75 ± 0.17 log10 cfu/mL/h) in the treatment of experimental meningitis in rabbits caused by a penicillin-resistant pneumococcal strain (MIC 4 mg/L). It was significantly more effective than the standard regimen, ceftriaxone with vancomycin, which led to a decrease of 0.53 ± 0.17 log10 cfu/mL/h. The addition of cefepime to gatifloxacin slightly improved the killing rates (giving a decrease of 0.84 ± 0.14 log10 cfu/mL/h). In vitro, synergy was demonstrated between cefepime and gatifloxacin by the chequerboard method (fractional inhibitory concentration index = 0.5) and by viable counts over 8 h.

* Corresponding author. Tel: +41-31-6322111; Fax: +41-31-6323847; E-mail: pcottagn{at}insel.ch


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
S. Ribes, F. Taberner, A. Domenech, C. Cabellos, F. Tubau, J. Linares, P. F. Viladrich, and F. Gudiol
Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae
J. Antimicrob. Chemother., May 1, 2006; 57(5): 931 - 936.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
P. Cottagnoud, M. Cottagnoud, and M. G. Tauber
Vancomycin Acts Synergistically with Gentamicin against Penicillin-Resistant Pneumococci by Increasing the Intracellular Penetration of Gentamicin
Antimicrob. Agents Chemother., January 1, 2003; 47(1): 144 - 147.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.